Cabot Benjamin Graham Value Investor Special Bulletin

You are trying to access subscriber-only content.

If you are a subscriber, log in here.

If you are not a subscriber, click here for your subscription. Subscribers will have unlimited access to our magazine articles and more!

Article Excerpt

Based on new data and improved prospects, I have raised my Min Sell Price for Gilead Sciences to 79.79 from 71.83.

Comments

You must be logged in to post a comment.